A recent finding published in the journal Nature Chemical Biology reports the synthesis of a carbohydrate-based vaccine for cancer. The study carried out in mice demonstrated that the vaccine triggers a strong immune response to cancer cells. The vaccine has been created synthetically and has shown promising results in creating an antibody response that can kill cultured epithelial cells derived from mice. The results are highly encouraging and “astounding”. However, Geert-Jan Boons, Franklin professor of chemistry and the lead author cautions, “There’s a very big step going from mice to humans,”. Read the full story here.